Back
Palisade Bio Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
26
PALI
Palisade Bio
Last Price:
2.22
Seasonality Move:
2.49%
Sell
48
NBY
NovaBay Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-7.72%
Sell
26
Palisade Bio (PALI)
is a Sell
Is Palisade Bio a Buy, Sell or Hold?
- The current Palisade Bio [PALI] share price is $2.30. The Score for PALI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- PALI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.78. The Score for NBY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PALI Stock Price Chart
What is Palisade Bio's stock price today?
-
The Palisade Bio share price today is $2.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PALI is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.78
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
PALI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 25.79 | Sell |
Chaikin Money Flow: | -35071 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.73 - 3.67) | Sell |
Bollinger Bands (100): | (3.19 - 4.23) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 63.49 | Buy |
Chaikin Money Flow: | 94062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.59 - 0.73) | Buy |
Bollinger Bands (100): | (0.29 - 1.65) | Sell |
PALI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.6 | Sell |
20-day SMA: | 3.15 | Sell |
50-day SMA: | 3.4 | Sell |
200-day SMA: | 4.85 | Sell |
8-day EMA: | 2.62 | Sell |
20-day EMA: | 2.96 | Sell |
50-day EMA: | 3.32 | Sell |
200-day EMA: | 9.18 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.73 | Buy |
20-day SMA: | 0.66 | Buy |
50-day SMA: | 0.62 | Buy |
200-day SMA: | 2.52 | Sell |
8-day EMA: | 0.72 | Buy |
20-day EMA: | 0.69 | Buy |
50-day EMA: | 0.74 | Buy |
200-day EMA: | 5.97 | Sell |
Palisade Bio Earnings Growth & PALI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.79 per share, and an increase next year of $4.22 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Palisade Bio Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |